4-Methylchrysoeriol

CAS No. 4712-12-3

4-Methylchrysoeriol( —— )

Catalog No. M32178 CAS No. 4712-12-3

4'-Methylchrysoeriol is a potent inhibitor of cytochrome P450 enzymes (IC50: 19 nM for human P450 1B1-dependent EROD).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
5MG 336 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    4-Methylchrysoeriol
  • Note
    Research use only, not for human use.
  • Brief Description
    4'-Methylchrysoeriol is a potent inhibitor of cytochrome P450 enzymes (IC50: 19 nM for human P450 1B1-dependent EROD).
  • Description
    4'-Methylchrysoeriol is a potent inhibitor of cytochrome P450 enzymes (IC50: 19 nM for human P450 1B1-dependent EROD).
  • In Vitro
    4'-Methylchrysoeriol (34DM57DHF) is a potent inhibitor of P450 enzymes, particularly for P450 1B1, with an IC50 of 19 nM for human P450 1B1-dependent EROD.
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4712-12-3
  • Formula Weight
    314.3
  • Molecular Formula
    C17H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20.83 mg/mL (66.28 mM)
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Isophorone

    Isophorone (355-trimethyl-2-cyclohexen-1-one) a monoterpene and the structurally related 18-cineole and camphor have demonstrated a protective effect against cancer biological activity against a variety of microorganisms and anti-oxidant properties.

  • Morpholinylmercaptob...

    Morpholinylmercaptobenzothiazole is an aftereffect rapid vulcanization accelerator.

  • Nemorubicin

    Nemorubicin is a doxorubicin derivative that differs significantly from its parent drug in terms of spectrum of antitumor activity, metabolism and toxicity profile.?